Skip to content

Antibiotic resistant (ABR) hotspots in the population of Rotterdam: a feasibility study for a future population-based prevalence study

Antibiotic resistant (ABR) hotspots in the population of Rotterdam: a feasibility study for a future population-based prevalence study - ABR population Rotterdam

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43243
Enrollment
400
Registered
2016-07-13
Start date
2016-03-15
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antibiotic resistance - resistant bacteria

Interventions

None listed

Sponsors

GGD Rotterdam-Rijnmond
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Adult (18 years and older) 2. Physically and mentally able to consent and participate (capacitated) 3. Resident of Rotterdam 4. Officially enrolled in the GP practice where enrollment takes place 5. Provides informed consent

Exclusion criteria

Exclusion criteria: All those not eligible according to the inclusion criteria. Additionally, a potential subject who shows inability to communicate with the research team in Dutch or otherwise, will also be excluded from the participation in the study.

Design outcomes

Primary

MeasureTime frame
Prevalence (%) of antibiotic resistant E. coli, S. aureus and K. pneumoniae strains in a population sample of residents of Rotterdam.

Secondary

MeasureTime frame
Associations between the presence of antibiotic resistance and riskfactors such as age, sex, travel history, antibiotic use, hospital admissions and workplace.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)